Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Maloney

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|September 28, 2006
The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and miceDebomoy K Lahiri, DeMao Chen, Bryan Maloney, et al.
Brain Communications|April 4, 2024
Micro-RNA profiles of pathology and resilience in posterior cingulate cortex of cognitively intact eldersChristy M Kelley, Bryan Maloney, John S Beck, et al.
Journal of Alzheimer'S Disease : JAD|March 13, 2008
Co-localization and distribution of cerebral APP and SP1 and its relationship to amyloidogenesisBrian Brock, Riyaz Basha, Katie DiPalma, et al.
Psychiatric Genetics|April 10, 2007
Temperamental fearfulness in childhood and the serotonin transporter promoter region polymorphism: a multimethod association studyElizabeth P Hayden, Lea R Dougherty, Bryan Maloney, et al.
Journal of Psychiatric Research|October 11, 2014
Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein markerCraig A Erickson, Balmiki Ray, Bryan Maloney, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisDebomoy K Lahiri, Ruizhi Wang, Bryan Maloney, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumDebomoy K Lahiri, Ruizhi Wang, Bryan Maloney, et al.
Journal of Affective Disorders|September 7, 2007
Early-emerging cognitive vulnerability to depression and the serotonin transporter promoter region polymorphismElizabeth P Hayden, Lea R Dougherty, Bryan Maloney, et al.
Molecular Psychiatry|January 17, 2020
MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moietiesNipun Chopra, Ruizhi Wang, Bryan Maloney, et al.
Journal of Alzheimer'S Disease : JAD|July 9, 2009
Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and miceRemi Dosunmu, Jinfang Wu, Lina Adwan, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|September 28, 2006
The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and miceDebomoy K Lahiri, DeMao Chen, Bryan Maloney, et al.
Brain Communications|April 4, 2024
Micro-RNA profiles of pathology and resilience in posterior cingulate cortex of cognitively intact eldersChristy M Kelley, Bryan Maloney, John S Beck, et al.
Journal of Alzheimer'S Disease : JAD|March 13, 2008
Co-localization and distribution of cerebral APP and SP1 and its relationship to amyloidogenesisBrian Brock, Riyaz Basha, Katie DiPalma, et al.
Psychiatric Genetics|April 10, 2007
Temperamental fearfulness in childhood and the serotonin transporter promoter region polymorphism: a multimethod association studyElizabeth P Hayden, Lea R Dougherty, Bryan Maloney, et al.
Journal of Psychiatric Research|October 11, 2014
Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein markerCraig A Erickson, Balmiki Ray, Bryan Maloney, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisDebomoy K Lahiri, Ruizhi Wang, Bryan Maloney, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumDebomoy K Lahiri, Ruizhi Wang, Bryan Maloney, et al.
Journal of Affective Disorders|September 7, 2007
Early-emerging cognitive vulnerability to depression and the serotonin transporter promoter region polymorphismElizabeth P Hayden, Lea R Dougherty, Bryan Maloney, et al.
Molecular Psychiatry|January 17, 2020
MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moietiesNipun Chopra, Ruizhi Wang, Bryan Maloney, et al.
Journal of Alzheimer'S Disease : JAD|July 9, 2009
Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and miceRemi Dosunmu, Jinfang Wu, Lina Adwan, et al.
Pageof 8